GMMMG logo

NHS photos

NHS logo

News

<< Back

News Summary

From this page you will be able to access a summary of additions or changes to the GMMMG website during January 2017

January 2017

 

Pathways and Guidelines Development Subgroup (PaGDSG)

27.1.17

The following Shared Care Protocols had minor amendments to them approved at the January 2017 meeting of the Pathways and Guidelines Development Subgroup:

  • The Prescribing and Monitoring of Oral Second Generation (Atypical) Antipsychotics for Adults – addition of Treatment of depression – adjunctive treatment as indication in this section 3 as it listed as indication in section 2 & 8 and is a licensed indication for Quetiapine MR.
  • The Prescribing and Monitoring of Oral Second Generation (Atypical) Antipsychotics for Adults - amended the wording in Adverse drug reactions for Hyperprolactinaemia  to mirror that in the SCP for First generation (Typical) antipsychotic depots in adults
  • Risperidone Long-acting antipsychotic injection - amended the wording in Adverse drug reactions for Hyperprolactinaemia  to mirror that in the SCP for First generation (Typical) antipsychotic depots in adults
  • Aripiprazole Long-acting antipsychotic injection - amended the wording in Adverse drug reactions for Hyperprolactinaemia  to mirror that in the SCP for First generation (Typical) antipsychotic depots in adults
  • Paliperidone Long-acting antipsychotic injection - amended the wording in Adverse drug reactions for Hyperprolactinaemia  to mirror that in the SCP for First generation (Typical) antipsychotic depots in adults

The updated versions are now available on the GMMMG website

GMMMG

04.01.17

GMMMG discussed the two types of flu vaccines available at their meeting in December and have issued a statement which is available here

<< Back

Line

TERMS AND CONDITIONS    |    CONTACT US    |    ABOUT US    |    ARCHIVE

RSS Feed
 
spacer